Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
35.7M
-
Shares change
-
-926K
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
-$27.7M
-
Put/Call ratio
-
0.02
-
Number of buys
-
108
-
Number of sells
-
-116
-
Price
-
$29.57
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q2 2025
259 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q2 2025.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.7M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.34M shares), Rubric Capital Management LP (3.16M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.64M shares), VANGUARD GROUP INC (2.25M shares), Invesco Ltd. (1.58M shares), RENAISSANCE TECHNOLOGIES LLC (1.52M shares), PRINCIPAL FINANCIAL GROUP INC (1.47M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.43M shares), STATE STREET CORP (1.35M shares), and DIMENSIONAL FUND ADVISORS LP (861K shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.